Elevance Health Inc (ELV)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	176,810,000	174,015,000	171,719,000	171,745,000	171,340,000	167,687,000	164,777,000	159,737,000	155,660,000	151,551,000	147,434,000	142,653,000	136,943,000	133,882,000	129,218,000	124,631,000	121,867,000	117,450,000	112,966,000	109,168,000
Property, plant and equipment	US$ in thousands	—	—	—	—	—	4,248,000	4,547,000	4,418,000	4,316,000	4,197,000	4,090,000	3,986,000	3,919,000	4,520,000	4,416,000	3,533,000	3,483,000	3,363,000	3,427,000	3,350,000
Fixed asset turnover		—	—	—	—	—	39.47	36.24	36.16	36.07	36.11	36.05	35.79	34.94	29.62	29.26	35.28	34.99	34.92	32.96	32.59

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $176,810,000K ÷ $—K
= —

The fixed asset turnover ratio measures how efficiently a company generates sales from its investment in fixed assets. For Elevance Health Inc, the trend in the fixed asset turnover ratio has shown a consistent increase from March 31, 2020, to September 30, 2023. The ratio improved steadily from 32.59 to 39.47 during this period, indicating that the company effectively utilized its fixed assets to generate revenue.

However, there is missing data from December 31, 2023, onwards, making it challenging to assess the recent performance accurately. It is essential for the company to provide complete financial data to ensure a comprehensive analysis of its fixed asset turnover ratio in future periods.

Overall, the increasing trend in the fixed asset turnover ratio reflects a positive sign of efficiency in utilizing fixed assets to drive sales for Elevance Health Inc. Continued monitoring of this ratio will provide insights into the company's operational effectiveness and asset management practices.